Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 Jul;91(3):601–608. doi: 10.1111/j.1476-5381.1987.tb11253.x

The affinities, potencies and efficacies of some benzodiazepine-receptor agonists, antagonists and inverse-agonists at rat hippocampal GABAA-receptors.

J A Kemp, G R Marshall, E H Wong, G N Woodruff
PMCID: PMC1853533  PMID: 3038246

Abstract

The abilities of some benzodiazepine-receptor agonists, antagonists and inverse agonists to modulate the inhibitory potency of the gamma-aminobutyric acid (GABA)A-receptor agonist, isoguvacine, on the CA1 population spike recorded from slices of rat hippocampus, were determined. Concentration-response curves were constructed of the extent to which the benzodiazepine-receptor ligands shifted the isoguvacine concentration-response curve to the left or right. These were compared to their displacement curves of [3H]-Ro15-1788 binding to rat hippocampal membranes under near physiological assay conditions. The above comparisons suggest that the effect on the potency of isoguvacine produced by the benzodiazepine-receptor agonists, diazepam and flunitrazepam, and the partial agonists, Ro16-6028 and Ro17-1812, closely parallels their degree of benzodiazepine-receptor occupancy. Thus, the partial agonists, Ro16-6028 and Ro17-1812, were unable to produce as large a maximum response as the full agonists, diazepam and flunitrazepam. The maximum effects produced by diazepam, flunitrazepam, Ro16-6028, Ro17-1812, the antagonist, propyl-beta-carboline-3-carboxylate, and the inverse agonist, methyl-6, 7-dimethyl-4-ethyl-beta-carboline-3-carboxylate (DMCM), on the potency of isoguvacine in the hippocampal slice corresponded to the change in their affinities produced by the addition of GABA in the radioligand binding studies (GABA-shift). This suggests that the changes in affinity of benzodiazepine-receptor ligands produced by GABAA-receptor activation reflects their ability to modify GABAA-receptor function. The benzodiazepine-receptor antagonists, Ro15-1788 and CGS 8216, had apparent agonist and inverse agonist effects, respectively, on the potency of isoguvacine. These effects occurred at concentrations above those required for saturation of the benzodiazepine-receptor, as labelled by [3H]-Ro15-1788, and were not in agreement with the absence of any effect of GABAA-receptor stimulation in the GABA-shift experiments.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
603

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albertson T. E., Bowyer J. F., Paule M. G. Modification of the anticonvulsant efficacy of diazepam by Ro-15-1788 in the kindled amygdaloid seizure model. Life Sci. 1982 Oct 11;31(15):1597–1601. doi: 10.1016/0024-3205(82)90051-0. [DOI] [PubMed] [Google Scholar]
  2. Bowery N. G., Hill D. R., Hudson A. L. Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. Br J Pharmacol. 1983 Jan;78(1):191–206. doi: 10.1111/j.1476-5381.1983.tb09380.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Braestrup C., Honoré T., Nielsen M., Petersen E. N., Jensen L. H. Ligands for benzodiazepine receptors with positive and negative efficacy. Biochem Pharmacol. 1984 Mar 15;33(6):859–862. doi: 10.1016/0006-2952(84)90438-6. [DOI] [PubMed] [Google Scholar]
  4. Braestrup C., Schmiechen R., Neef G., Nielsen M., Petersen E. N. Interaction of convulsive ligands with benzodiazepine receptors. Science. 1982 Jun 11;216(4551):1241–1243. doi: 10.1126/science.6281892. [DOI] [PubMed] [Google Scholar]
  5. Brown C. L., Martin I. L. Kinetics of [3H]Ro 15-1788 binding to membrane-bound rat brain benzodiazepine receptors. J Neurochem. 1984 Apr;42(4):918–923. doi: 10.1111/j.1471-4159.1984.tb12691.x. [DOI] [PubMed] [Google Scholar]
  6. Chan C. Y., Farb D. H. Modulation of neurotransmitter action: control of the gamma-aminobutyric acid response through the benzodiazepine receptor. J Neurosci. 1985 Sep;5(9):2365–2373. doi: 10.1523/JNEUROSCI.05-09-02365.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Choi D. W., Farb D. H., Fischbach G. D. Chlordiazepoxide selectively augments GABA action in spinal cord cell cultures. Nature. 1977 Sep 22;269(5626):342–344. doi: 10.1038/269342a0. [DOI] [PubMed] [Google Scholar]
  8. Choi D. W., Farb D. H., Fischbach G. D. Chlordiazepoxide selectively potentiates GABA conductance of spinal cord and sensory neurons in cell culture. J Neurophysiol. 1981 Apr;45(4):621–631. doi: 10.1152/jn.1981.45.4.621. [DOI] [PubMed] [Google Scholar]
  9. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978 Aug;235(2):E97–102. doi: 10.1152/ajpendo.1978.235.2.E97. [DOI] [PubMed] [Google Scholar]
  10. Ehlert F. J., Roeske W. R., Gee K. W., Yamamura H. I. An allosteric model for benzodiazepine receptor function. Biochem Pharmacol. 1983 Aug 15;32(16):2375–2383. doi: 10.1016/0006-2952(83)90679-2. [DOI] [PubMed] [Google Scholar]
  11. Grecksch G., de Carvalho L. P., Venault P., Chapouthier G., Rossier J. Convulsions induced by submaximal dose of pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist Ro 15-1788. Life Sci. 1983 May 30;32(22):2579–2584. doi: 10.1016/0024-3205(83)90241-2. [DOI] [PubMed] [Google Scholar]
  12. Hunkeler W., Möhler H., Pieri L., Polc P., Bonetti E. P., Cumin R., Schaffner R., Haefely W. Selective antagonists of benzodiazepines. Nature. 1981 Apr 9;290(5806):514–516. doi: 10.1038/290514a0. [DOI] [PubMed] [Google Scholar]
  13. Jensen L. H., Petersen E. N., Braestrup C. Audiogenic seizures in DBA/2 mice discriminate sensitively between low efficacy benzodiazepine receptor agonists and inverse agonists. Life Sci. 1983 Jul 25;33(4):393–399. doi: 10.1016/s0024-3205(83)80014-9. [DOI] [PubMed] [Google Scholar]
  14. Jensen M. S., Lambert J. D. Modulation of the responses to the GABA-mimetics, THIP and piperidine-4-sulphonic acid, by agents which interact with benzodiazepine receptors. An electrophysiological study on cultured mouse neurones. Neuropharmacology. 1984 Dec;23(12A):1441–1450. doi: 10.1016/0028-3908(84)90087-x. [DOI] [PubMed] [Google Scholar]
  15. Karobath M., Supavilai P., Borea P. A. Distinction of benzodiazepine receptor agonists and inverse agonists by binding studies in vitro. Adv Biochem Psychopharmacol. 1983;38:37–45. [PubMed] [Google Scholar]
  16. Kemp J. A., Marshall G. R., Woodruff G. N. Quantitative evaluation of the potencies of GABA-receptor agonists and antagonists using the rat hippocampal slice preparation. Br J Pharmacol. 1986 Apr;87(4):677–684. doi: 10.1111/j.1476-5381.1986.tb14585.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Korneyev AYa Benzodiazepines stimulate muscimol receptor binding in an Ro 15-1788 reversible manner. Eur J Pharmacol. 1983 Jun 3;90(2-3):227–230. doi: 10.1016/0014-2999(83)90241-8. [DOI] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. Macdonald R., Barker J. L. Benzodiazepines specifically modulate GABA-mediated postsynaptic inhibition in cultured mammalian neurones. Nature. 1978 Feb 9;271(5645):563–564. doi: 10.1038/271563a0. [DOI] [PubMed] [Google Scholar]
  20. Matsumoto K., Fukuda H. Stimulatory and protective effects of benzodiazepines on GABA receptors labeled with [3H]muscimol. Life Sci. 1982 Mar 15;30(11):935–943. doi: 10.1016/0024-3205(82)90622-1. [DOI] [PubMed] [Google Scholar]
  21. Möhler H., Burkard W. P., Keller H. H., Richards J. G., Haefely W. Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels. J Neurochem. 1981 Sep;37(3):714–722. doi: 10.1111/j.1471-4159.1982.tb12546.x. [DOI] [PubMed] [Google Scholar]
  22. Möhler H., Richards J. G. Agonist and antagonist benzodiazepine receptor interaction in vitro. Nature. 1981 Dec 24;294(5843):763–765. doi: 10.1038/294763a0. [DOI] [PubMed] [Google Scholar]
  23. Nistri A., Berti C. Potentiating action of midazolam on GABA-mediated responses and its antagonism by Ro 14-7437 in the frog spinal cord. Neurosci Lett. 1983 Aug 29;39(2):199–204. doi: 10.1016/0304-3940(83)90077-0. [DOI] [PubMed] [Google Scholar]
  24. Nistri A., Constanti A. Effects of flurazepam on amino acid-evoked responses recorded from the lobster muscle and the frog spinal cord. Neuropharmacology. 1978 Feb;17(2):127–135. doi: 10.1016/0028-3908(78)90125-9. [DOI] [PubMed] [Google Scholar]
  25. Nutt D. J., Cowen P. J., Little H. J. Unusual interactions of benzodiazepine receptor antagonists. Nature. 1982 Feb 4;295(5848):436–438. doi: 10.1038/295436a0. [DOI] [PubMed] [Google Scholar]
  26. O'Brien R. A., Schlosser W., Spirt N. M., Franco S., Horst W. D., Polc P., Bonetti E. P. Antagonism of benzodiazepine receptors by beta carbolines. Life Sci. 1981 Jul 6;29(1):75–82. doi: 10.1016/0024-3205(81)90117-x. [DOI] [PubMed] [Google Scholar]
  27. Olsen R. W. Drug interactions at the GABA receptor-ionophore complex. Annu Rev Pharmacol Toxicol. 1982;22:245–277. doi: 10.1146/annurev.pa.22.040182.001333. [DOI] [PubMed] [Google Scholar]
  28. Petrack B., Czernik A. J., Cassidy J. P., Bernard P., Yokoyama N. Benzodiazepine receptor ligands with opposing pharmacologic actions. Adv Biochem Psychopharmacol. 1983;38:129–137. [PubMed] [Google Scholar]
  29. Phillis J. W., Edstrom J. P., Ellis S. W., Kirkpatrick J. R. Theophylline antagonizes flurazepam-induced depression of cerebral cortical neurons. Can J Physiol Pharmacol. 1979 Aug;57(8):917–920. doi: 10.1139/y79-140. [DOI] [PubMed] [Google Scholar]
  30. Polc P., Bonetti E. P., Schaffner R., Haefely W. A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, beta-carbolines, and phenobarbitone. Naunyn Schmiedebergs Arch Pharmacol. 1982 Dec;321(4):260–264. doi: 10.1007/BF00498510. [DOI] [PubMed] [Google Scholar]
  31. Robertson H. A., Riives M. L. A benzodiazepine antagonist is an anticonvulsant in an animal model for limbic epilepsy. Brain Res. 1983 Jul 4;270(2):380–382. doi: 10.1016/0006-8993(83)90619-4. [DOI] [PubMed] [Google Scholar]
  32. Simmonds M. A. Antagonism of flurazepam and other effects of Ro15-1788, PK8165 and Ro5-4864 on the GABA-A receptor complex in rat cuneate nucleus. Eur J Pharmacol. 1985 Oct 29;117(1):51–60. doi: 10.1016/0014-2999(85)90471-6. [DOI] [PubMed] [Google Scholar]
  33. Skerritt J. H., Johnston G. A. Enhancement of GABA binding by benzodiazepines and related anxiolytics. Eur J Pharmacol. 1983 May 6;89(3-4):193–198. doi: 10.1016/0014-2999(83)90494-6. [DOI] [PubMed] [Google Scholar]
  34. Skerritt J. H., Macdonald R. L. Benzodiazepine Ro 15-1788: electrophysiological evidence for partial agonist activity. Neurosci Lett. 1983 Dec 30;43(2-3):321–326. doi: 10.1016/0304-3940(83)90208-2. [DOI] [PubMed] [Google Scholar]
  35. Skerritt J. H., Macdonald R. L. Benzodiazepine receptor ligand actions on GABA responses. Benzodiazepines, CL 218872, zopiclone. Eur J Pharmacol. 1984 May 18;101(1-2):127–134. doi: 10.1016/0014-2999(84)90038-4. [DOI] [PubMed] [Google Scholar]
  36. Skerritt J. H., Macdonald R. L. Benzodiazepine receptor ligand actions on GABA responses. Beta-carbolines, purines. Eur J Pharmacol. 1984 May 18;101(1-2):135–141. doi: 10.1016/0014-2999(84)90039-6. [DOI] [PubMed] [Google Scholar]
  37. Vellucci S. V., Webster R. A. Is Ro15-1788 a partial agonist at benzodiazepine receptors? Eur J Pharmacol. 1983 Jun 3;90(2-3):263–268. doi: 10.1016/0014-2999(83)90247-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES